CKW Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2K Hold
50
﹤0.01% 128
2025
Q4
$3K Sell
50
-10
-17% -$511 ﹤0.01% 147
2025
Q3
$4K Buy
60
+10
+20% +$585 ﹤0.01% 142
2025
Q2
$3K Buy
50
+20
+67% +$1.36K ﹤0.01% 148
2025
Q1
$2K Hold
30
﹤0.01% 160
2024
Q4
$3K Hold
30
﹤0.01% 212
2024
Q3
$4K Hold
30
﹤0.01% 193
2024
Q2
$4K Hold
30
﹤0.01% 193
2024
Q1
$4K Buy
+30
New +$3.57K ﹤0.01% 196
2015
Q3
Sell
-2,074
Closed -$57K 247
2015
Q2
$57K Sell
2,074
-442
-18% -$12.4K 0.02% 97
2015
Q1
$69K Hold
2,516
0.03% 89
2014
Q4
$53K Sell
2,516
-452
-15% -$10.1K 0.02% 104
2014
Q3
$71K Sell
2,968
-282
-9% -$6.49K 0.03% 76
2014
Q2
$75K Hold
3,250
0.04% 70
2014
Q1
$73K Hold
3,250
0.03% 75
2013
Q4
$60K Buy
+3,250
New +$56.6K 0.03% 83

Other funds holding NVO

CKW Financial Group's NVO Position: Q1 2026 in Review

CKW Financial Group held its Novo Nordisk (NVO) position steady in Q1 2026 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #128.

CKW Financial Group first reported a position in NVO in Q4 2013 and has held it in 16 quarters since. The position peaked at $75K in Q2 2014. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • CKW Financial Group held 50 shares of Novo Nordisk worth $2K as of Q1 2026.
  • CKW Financial Group left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of CKW Financial Group's portfolio in Q1 2026, its #128 holding.
  • CKW Financial Group first reported a position in Novo Nordisk in Q4 2013 and has held it in 16 quarters since.
  • CKW Financial Group's Novo Nordisk position peaked at $75K in Q2 2014.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on CKW Financial Group's 13F filing for Q1 2026, filed 7 May 2026.